Medivation

Pharma

Kadmon adviser enriched himself during $1.9B Sanofi deal: SEC

For one financial adviser, the urge to profit off Sanofi’s $1.9 billion Kadmon buyout allegedly proved too powerful to resist.
Fraiser Kansteiner May 25, 2022 10:45am

A former Medivation exec is facing insider trading charges

Aug 17, 2021 11:18am

Torrent drops out of Sanofi EU generics auction over price: report

Apr 5, 2018 11:31am

After two high-profile M&A fails, how did Sanofi win Bioverativ?

Feb 9, 2018 11:04am

J&J's blockbuster Zytiga faces 2018 generic threat

Jan 18, 2018 10:31am

Kite chief up for $600M-plus payday in Gilead buyout

Aug 31, 2017 11:55am